Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;28(9):1082-1090.
doi: 10.1017/S1047951118001075. Epub 2018 Jul 11.

Clinical pharmacology considerations for children supported with ventricular assist devices

Affiliations
Review

Clinical pharmacology considerations for children supported with ventricular assist devices

Jennifer Sherwin et al. Cardiol Young. 2018 Sep.

Abstract

The ventricular assist device is being increasingly used as a "bridge-to-transplant" option in children with heart failure who have failed medical management. Care for this medically complex population must be optimised, including through concomitant pharmacotherapy. Pharmacokinetic/pharmacodynamic alterations affecting pharmacotherapy are increasingly discovered in children supported with extracorporeal membrane oxygenation, another form of mechanical circulatory support. Similarities between extracorporeal membrane oxygenation and ventricular assist devices support the hypothesis that similar alterations may exist in ventricular assist device-supported patients. We conducted a literature review to assess the current data available on pharmacokinetics/pharmacodynamics in children with ventricular assist devices. We found two adult and no paediatric pharmacokinetic/pharmacodynamic studies in ventricular assist device-supported patients. While mechanisms may be partially extrapolated from children supported with extracorporeal membrane oxygenation, dedicated investigation of the paediatric ventricular assist device population is crucial given the inherent differences between the two forms of mechanical circulatory support, and pathophysiology that is unique to these patients. Commonly used drugs such as anticoagulants and antibiotics have narrow therapeutic windows with devastating consequences if under-dosed or over-dosed. Clinical studies are urgently needed to improve outcomes and maximise the potential of ventricular assist devices in this vulnerable population.

Keywords: Ventricular assist device; children; clinical pharmacology; pharmacodynamics; pharmacokinetics.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Mechanisms of altered drug disposition during mechanical circulatory support
This figure displays the mechanisms of altered drug disposition during mechanical circulatory support and is shown according to device and patient properties.

References

    1. Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail 2009; 2: 63–70. - PubMed
    1. Rossano JW, Dipchand AI, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. J Heart Lung Transplant 2016; 35: 1185–1195. - PubMed
    1. Almond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009; 119: 717–727. - PMC - PubMed
    1. Zafar F, Castleberry C, Khan MS, et al. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices. J Heart Lung Transplant 2015; 34: 82–88. - PubMed
    1. Section on Cardiology and Cardiac Surgery; Section on Orthopaedics. Off-label use of medical devices in children. Pediatrics 2017; 139 pii: e20163439. doi: 10.1542/peds.2016-3439. - DOI - PubMed

MeSH terms